Track the Cannara Biotech Inc. share price and the full management transaction log of the company, a listed equity based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €193.6m. The latest transaction was disclosed on 31 July 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Landry, France. All data is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,961 of 29,064 companies
68.6
score / 100
Value
73
Quality
64
FCF yld6.9%
Earn yld6.7%
EV/EBITDA8.3x
ROE9.7%
Gross mgn44%
Net mgn12%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.